Clinical Benefit with Palbociclib in Estrogen Receptor Positive, Her2-Negative Metastatic Breast Cancer: New Concepts

The main objective in patients with MBC(Metastatic Breast Cancer) is the prolongation of survival as well as of improvements in time to progression and duration of response [1]. The most important advanced in the improvement of survival has been the development of specific...